Reuters logo
8 months ago
BRIEF-Cerus announces exercise of additional BARDA contract options for activities related to its planned Phase III trial of the Intercept Red Blood Cell System
December 19, 2016 / 2:02 PM / 8 months ago

BRIEF-Cerus announces exercise of additional BARDA contract options for activities related to its planned Phase III trial of the Intercept Red Blood Cell System

Dec 19 (Reuters) - Cerus Corp

* Cerus Corp - Total value of full five-year contract has also increased to be worth up to $185 million in non-dilutive funding to Cerus

* Cerus announces exercise of additional BARDA contract options totaling $10,825,555 for activities related to its planned Phase III Trial of the Intercept Red Blood Cell System Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below